Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients' lives.

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for ...

On the occasion of its deal with Cure51, find out about NVIDIA's biotech strategy as it gets more and more involved in the ...

Since the approval of Luxturna, there has been a wave of gene therapies advancing in clinical trials to treat genetic vision ...